stachydrine has been researched along with Liver Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Guan, W; Liu, Z; Peng, X; Wei, X; Wu, Y; Xiong, B; Yang, A; Zhang, J | 1 |
1 other study(ies) available for stachydrine and Liver Cirrhosis
| Article | Year |
|---|---|
Stachydrine ameliorates carbon tetrachloride-induced hepatic fibrosis by inhibiting inflammation, oxidative stress and regulating MMPs/TIMPs system in rats.
Topics: Animals; Carbon Tetrachloride; Cell Line; Inflammation; Liver; Liver Cirrhosis; Male; Metalloendopeptidases; Oxidative Stress; Proline; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinases | 2018 |